Study of estradiol valerate for prevention of uterine adhesion after hysteroscopic adhesiolysis

LIN Yi; et al

doi:10.13406/j.cnki.cyxb.2011.03.024

您当前的位置：

首页 >

文章列表页 >

Study of estradiol valerate for prevention of uterine adhesion after hysteroscopic adhesiolysis

更新时间：2024-01-17

- Study of estradiol valerate for prevention of uterine adhesion after hysteroscopic adhesiolysis
- Journal of Chongqing Medical University Vol. 36, Issue 3, Pages: 359-361(2011)
- 作者机构：
  
  重庆市妇幼保健院生殖内分泌科
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.2011.03.024
  CLC： R713
- Published：2011，
扫描看全文
[1]林奕,李莉,雷丽,郝丽娟,雷莉,孙文洁.戊酸雌二醇用于宫腔粘连分离术后防止再粘连的研究[J].重庆医科大学学报,2011,36(03):359-361.

LIN Yi, et al. Study of estradiol valerate for prevention of uterine adhesion after hysteroscopic adhesiolysis. [J]. Journal of Chongqing Medical University 36(3):359-361(2011)
[1]林奕,李莉,雷丽,郝丽娟,雷莉,孙文洁.戊酸雌二醇用于宫腔粘连分离术后防止再粘连的研究[J].重庆医科大学学报,2011,36(03):359-361. DOI： 10.13406/j.cnki.cyxb.2011.03.024.

LIN Yi, et al. Study of estradiol valerate for prevention of uterine adhesion after hysteroscopic adhesiolysis. [J]. Journal of Chongqing Medical University 36(3):359-361(2011) DOI： 10.13406/j.cnki.cyxb.2011.03.024.

摘要

目的:评价戊酸雌二醇（Estradiol valerate

E2V）用于术后防止宫腔粘连复发的效果。方法:宫腔镜下行宫腔粘连分离术和放置宫内避孕环后的患者

15例不用E2V

15例用E2V（9 mg/d）2月

15例用E2V（9 mg/d）3月。所有病例定期随诊

治疗结束后取出宫内避孕环

同时再行宫腔镜检查。结果:完成治疗后

用E2V3月组子宫内膜厚度最厚

不用E2V组最薄。宫腔形态及月经恢复正常率

用E2V 3月组达93.3%

用E2V 2月组达73.3%

而不用E2V组46.7%。结论:宫腔镜下宫腔粘连分离术后

同时口服E2V是防止宫腔粘连复发的有效方法。

Abstract

Objective: To evaluate the effects of estradiol valerate(E2V) on prevention of uterine adhesion after hysteroscopic adhesiolysis.Methods:After hysteroscopic adhesiolysis was performed and the intrauterine devices(IUDs) were put

fifteen patients weren’t treated with E2V

fifteen patients were treated with E2V(9 mg daily)for two months

and another fifteen patients were treated with E2V(9 mg daily)for three months.All cases were followed up.IUDs were taken out when treatment was finished and a second time hysteroscopy was performed.Results: When treatment was finished

the endometria of E2V for three months group were the thickest

and the no E2V group was the thinnest.In regard to the shape of uterine cavity and the return of menstruation to normal

E2V for three months group was 93.3%

E2V for two months group was 73.3%

and the no E2V group was only 46.7%.Conclusion: E2V is effective for the prevention of uterine adhesion after hysteroscopic adhesiolysis.

关键词

戊酸雌二醇宫腔镜分离术宫腔粘连

Keywords

estradiol valeratehysteroscopic adhesiolysisuterine adhesion

references

Views

443

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Analysis of the effect of readhesion of Combined application of chitosan and balloon stent in the prevention of severe intrauterine adhesions

Effect of different dosages of estrogen on ovarian function and ESR1 expression after hysteroscopic adhesiolysis

Effects of different doses of estradiol valerate on intrauterine adhesion in rats

Related Author

Xiao Tianhui

Le Aiwen

Zhuo Rong

Tao Yu

Wang Zhonghai

Zhou Qin

Li Qiong

Yuan Rui

Related Institution

Department of Gynecology,Affiliated Shenzhen Nanshan People’s Hospital of Guangdong Medical University

Department of Obstetrics and Gynecology,The First Affiliated Hospital of Chongqing Medical University

Department of Obstetrics and Gynecology,Zhujiang Hospital,Southern Medical University

⁰